| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))
CAS:114200-59-8
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))
CAS:114200-59-8
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))
CAS:114200-59-8
Purity:98% Package:500μg;1mg;5mg
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:1-β-D-Glucosylsphingadienine
CAS:114200-59-8
|
|
| | 1--D-Glucosylsphingadienine (d18:2 (4E,8E)) Basic information |
| Product Name: | 1--D-Glucosylsphingadienine (d18:2 (4E,8E)) | | Synonyms: | 1--D-Glucosylsphingadienine (d18:2 (4E,8E));β-D-Glucopyranoside, (2S,3R,4E,8E)-2-amino-3-hydroxy-4,8-octadecadienyl (9CI);1-β-D-Glucosylsphingadienine (d18:2 (4E,8E));1-β-D-Glucosylsphingadienine;2S-amino-3R-hydroxy-4E,8E-octadecadienyl,β-D-glucopyranoside | | CAS: | 114200-59-8 | | MF: | C24H45NO7 | | MW: | 459.62 | | EINECS: | | | Product Categories: | | | Mol File: | 114200-59-8.mol |  |
| | 1--D-Glucosylsphingadienine (d18:2 (4E,8E)) Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Chloroform:Methanol (4:1): Soluble | | form | A solid |
| | 1--D-Glucosylsphingadienine (d18:2 (4E,8E)) Usage And Synthesis |
| Description | 1-β-D-Glucosylsphingadienine is a glucosylsphingosine, which are deacetylated lysolipid derivatives of glucosylcerebrosides (Item Nos. 23206 | 23207). They are formed when sphingosines undergo glucosidation by UDP-glucose. Glucosylsphingosines completely reduce neurite outgrowth and induce death of LA-N-2 cells at concentrations of 10 and 50 μM, respectively. They also decrease the activity of glucocerebrosidase in LA-N-2 cells in a dose-dependent manner. Glucosylsphingosine levels are elevated in patients with Gaucher''s disease, both in the spleen (in types 1, 2, and 3) and brain (type 2 and 3); thus, glucosylsphingosine has been used as a key biomarker of the disease. This product contains 1-β-D-glucosylsphingadienine isolated from plants. [Matreya, LLC. Catalog No. 1310] |
| | 1--D-Glucosylsphingadienine (d18:2 (4E,8E)) Preparation Products And Raw materials |
|